Lysergic Acid Diethylamide–Assisted Therapy in Patients With Anxiety With and Without a Life-Threatening Illness: A Randomized, Double-Blind, Placebo-Controlled Phase II Study-Reference-Cited by-同舟云学术

Lysergic Acid Diethylamide–Assisted Therapy in Patients With Anxiety With and Without a Life-Threatening Illness: A Randomized, Double-Blind, Placebo-Controlled Phase II Study

Published:2023-02 Issue:3 Volume:93 Page:215-223
ISSN:0006-3223
Container-title:Biological Psychiatry
language:en
Short-container-title:Biological Psychiatry

Author:

Holze Friederike,Gasser Peter,Müller Felix,Dolder Patrick C.,Liechti Matthias E.^ORCID

Publisher

Elsevier BV

Subject

Biological Psychiatry

Reference25 articles.

1. Epidemiology of anxiety disorders in the 21st century;Bandelow;Dialogues Clin Neurosci,2015

2. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: A meta-analysis of 94 interview-based studies;Mitchell;Lancet Oncol,2011

3. Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action;Vollenweider;Neuroreport,1998

4. Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects;Holze;Neuropsychopharmacology,2021

5. The fabric of meaning and subjective effects in LSD-induced states depend on serotonin 2A receptor activation;Preller;Curr Biol,2017

Cited by 124 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ketanserin exhibits dose- and concentration-proportional serotonin 2A receptor occupancy in healthy individuals: Relevance for psychedelic research;European Neuropsychopharmacology;2024-11

2. Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life-threatening diseases;Cochrane Database of Systematic Reviews;2024-09-12

3. Chemical Reactivity Parameters to Analyze Psychedelics: How Do We Explain the Potency of the Drugs?;ACS Omega;2024-09-11

4. Large-scale brain connectivity changes following the administration of lysergic acid diethylamide, d-amphetamine, and 3,4-methylenedioxyamphetamine;Molecular Psychiatry;2024-09-11

5. Epigenetic mechanisms of rapid-acting antidepressants;Translational Psychiatry;2024-09-04